# Active Drug Surveillance Program of Ferriprox Use

> **NCT01838291** · — · COMPLETED · sponsor: **ApoPharma** · enrollment: 294 (actual)

## Conditions studied

- Transfusional Iron Overload

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01838291
- **Lead sponsor:** ApoPharma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 294 (ACTUAL)
- **Last updated:** 2013-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01838291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01838291, "Active Drug Surveillance Program of Ferriprox Use". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01838291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*